New insight into strategies used to develop long-acting g-csf biologics for neutropenia therapy

HIGHLIGHTS

• who: Abdulrahman Theyab and collaborators from the University of Florida, United States have published the research work: New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy, in the Journal: (JOURNAL)

SUMMARY

Frontiers in Oncology 2 Increasing the molecular weight of G-CSF to extend its half-life @@

ACRONYMS

LAY DEFINITIONS

• neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
• G-CSF: A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.